The World Trade Organization was set to decide on the patent waiver by Dec. 17, but now the USTR says the US government will not back the initiative until it has time to study its impact.
The announcement comes after the US backed a similar proposal in June covering COVID-19 vaccine know-how.
AHF has strongly supported the emergency waiver of patents on COVID-19 vaccines, diagnostics, and therapeutics through its Vaccinate Our World campaign since India and South Africa first introduced the idea at the World Trade Organization in 2020.
AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.6m people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe.
Takeda's HYQVIA gains FDA approval for CIDP maintenance therapy
ANGLE signs USD250,000 contract with Eisai for HER2 assay pilot study
genedrive secures initial overseas orders for Genedrive MT-RNR1 ID kit
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring
Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus